ETAL TREATMENTS

Girolami B, Bemardi E, Prins MH, etal. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl a meta-analysis. Arch Intern Med 1999 ... 

Mobler ER III, Hiatt WR, OlinJW, etal. Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin 12 analogue a double-blinded, randomized,... 

Chen CY, Kumar RN, Feng YH, etal. Treatment outcomes in patients receiving conventional amphotericin B therapy a prospective multicentre study in Taiwan. J Antimicrob Chemother 2006 57 1181-8. 

Jacobsen SJ, Jacobson DJ, Girman CJ, etal. Treatment for benign prostatic hyperplasia among community dwelling men The Olmsted County Study of urinary symptoms and health status. J Urol 1999 162 1301-1306. 

Uthman,B.M.etal., Treatment of epilepsy by stimulation of the vagus nerve. Neurology, 1993,43 1338-1345. 

A series of semiempirical MO treatments of the benzenediazonium ion and the phenyl cation were made in the 1960s and early 1970s. These results were superseded by some papers published between 1976 and 1981 by Schleyer s group (Dill etal., 1976, 1977), by Castenmiller and Buck (1977), by Vincent and Radom (1978), by the groups of Simonetta and Zollinger (Gamba et al., 1980), by Alcock et al. (1980 a), and by Tasaka et al. (1981). 

Variants of this method have been implemented by Noninski and Lazarova191 and Zelinskii and Bek192 Various specific aspects have been discussed by Lazarova.193,194 Theoretical treatments have been provided by Safonov etal,195... 

Let us compare these results with the predictions of the theory formulated by Lampe etal. (24) in terms of a steady-state concentration of collision complexes. This is a classical macroscopic treatment insofar as it makes no assumptions about the collision dynamics, but its postulate of collision complexes implies that v8 = vp/2 for the system treated above. Thus, its predictions might be expected to coincide with those of the collision-complex model. Figure 3 shows that this is not so the points calculated from the steady-state theory (Ref. 25, Equation 10) coincide exactly with the curve for which v8 = vv. The reason for this is that the steady-state treatment assumes a constant time available for reaction irrespective oC the number of reactions occurring in any one reaction... 

Tiihonen J, Ryynanen O-P, KauhanenJ, etal Citalopramin the treatment of alcoholism a double-blind placebo-controlled study. Pharmacopsychiatry 29 27-29, 1996... 

Milby JB, Sims, MK, KhuderS.etal Psychiatriccomorbidity prevalencein methadone maintenance treatment. Am J Drug Alcohol Abuse 22 95—107, 1996... 

Somoza EC, Winhusen TM, Bridge TP, et al An open-label pilot study of methylpheni-date in the treatment of cocaine-dependent patients with adult attention deficit/ hyperactivity disorder. J Addict Dis 23 77—92, 2004 Sora 1, Wichems C, Takahashi N, et al Cocaine reward models conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci U S A 95 7699-7704, 1998 Soral, Hall FS, Andrews AM, etal Molecular mechanisms of cocaine reward combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Nad Acad Sci U S A 98 5300-5305, 2001 Spear J, Alderton D Psychosis associated with prescribed dexamphetamine use 0etter). 

Haverkos HW, Pinsky PF, Drotman DP, etal Disease manifestation among homosexual men with acquired immunodeficiency syndrome a possible role of nitrites in Kaposi s sarcoma. Sex Transm Dis 12 203-208, 1985 Haverkos HW, Kopstein AN, Wilson H, et al Nitrite inhalants history, epidemiology, and possible links to AIDS. Environ Health Perspect 102 858-861, 1994 Hernandez-Avila CA, Ortega-Soto HA, Jasso A, et al Treatment of inhalant-induced psychotic disorder with carbamazepine versus haloperidol. Psychiatr Serv49 812— 815, 1998... 

O Malley SS, O Connor PG, Barren C,etal Naltrexone in the treatment of alcoholism new research (abstract). Biol Psychiatry49 (8, suppl) 14S, 2001... 

Cidofovir (Fig. 2) has been formally approved for the treatment of CMV retinitis in AIDS patients, where it is administered intravenously at a dose not exceeding 5 mg/kg once weekly during the first two weeks (and every other week thereafter). Cidofovir is also used off label for the treatment of human papilloma virus (HPV) infections (i.e., cutaneous warts, anogenital warts, laryngeal and pharyngeal papilloma), polyomavirus [i.e., progressive (i.e., multifocal leukoencephalopathy (PML)], adenovirus, herpesvirus, and poxvirus (i.e., molluscum contagiosum) infections, where it can be administered intravenously (at a dose of < 5 mg/kg once weekly or every other week) or topically as a 1% gel or cream (De Clercq and Holy 2005). Especially in immunosuppressed patients (i.e., transplant recipients), local treatment of HPV-associated lesions has often yielded spectacular results (Bonatti etal.2007). 

Mupirocin is a topical antibiotic that inhibits isoleucyl tRNA synthetase with the subsequent inhibition of protein synthesis. Mupirocin has become a mainstay in the treatment of Staph, aureus infection and colonization during hospital outbreaks, and it is in this organism that acquired resistance has arisen (Gilbart etal. 1993). 

Schwab S, Schwarz S, SprangerM, etal. Moderate hypothermiain the treatment of patients with severe middle cerebral artery infarction. Stroke 1998 29(12) 2461-2466. 

Studies have demonstrated that treatment with soy or phytoestrogen enriched diets is effective in conserving bone in rodent models of osteoporosis (Anderson and Gamer, 1998 Ishimi et al, 2000 Draper et al, 1997). The mechanism of action of phytoestrogens on bone health is unclear but several mechanisms including inhibition of bone resorption and stimulation of bone formation maybe involved (Fanti etal, 1998 Ishimi e/a/., 1999 Picherit eta/., 2000). Limited data from studies in postmenopausal women have indicated that phytoestrogen supplements have a small, beneficial effect on bone loss in the lumbar spine (Alekel et al, 2000 Potter et al, 1998 Somekawa et al, 2001). 

Phyto chemicals can be used to either stimulate or inhibit motility of the GIT. For example, caffeine and other phytochemicals stimulate motility (Lis-Balchim etal, 2001 Boekema et al, 1999), whereas motility is slowed by peppermint oil (Beesley et al, 1996), protease inhibitors (Schwartz et al., 1994) and several other phytochemicals (Abdullahi et al, 2001 Odetola and Acojenu, 2000 Rojas et al, 1999 Amos et al, 1998). Many of the traditional herbal medicines used for treatment of diarrhea are based on aqueous extracts that slow small intestine transit and increase residence time for digesta (Lin et al, 2002). The opiates and derivatives are particularly noteworthy (Williams et al., 1997). 

Although there is no data relating to free-radical activity in humans, several animal models have been developed (Parks etal., 1983). Pitt etal. (1991) showed that more severe injury occurred in the proximal small intestine, where levels of XO were highest. SOD has been reported to be protective in a rat model (Dalsing et al., 1983) and more recently a tungsten-supplemented diet was also found to be of benefit (Pitt et al., 1991). However, whether such treatment could modify the human disease, which usually develops within 10 days of birth, remains to be seen. 

Only one study to date has been conducted on the treatment of acute pancreatitis with antioxidants. Clemens et al. (1991) were unable to show any difference in the incidence or severity of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis in a prospective, randomized, double-blind, placebo-controlled trial of allopurinol. However, Salim (1991) performed a similar trial of the effect of allopurinol and DMSO in patients with pain from recurrent pancreatitis, and found significant benefit. On the basis that depletion of antioxidants is important in the pathogenesis of chronic pancreatitis, the administration of a cocktail of antioxidants was assessed for its effect on pain in this disease. Treatment with a combination of organic selenium, d-carotene, vitamins C and E, and methionine was of benefit in the initial pilot study, and in a placebo-controlled trial (San-dilands etal., 1990 Uden et al., 1990). 

Allopurinol has been shown to attenuate lipid peroxidation in ethanol-fed rats (Kato etal., 1990). However, this was not correlated with any possible effect on histological damage and, as discussed previously, the significance of lipid peroxidation is unclear. Despite the evidence suggesting that oxidative stress and increased oxidative metabolism may play a role in the pathogenesis of human alcoholic liver disease, it remains to be shown that treatment with specific antioxidants will modify this process. 

Treatment with iron chelators and a-tocopherol protect against lipid p>eroxidation and hepatocellular injury in iron-overloaded rats (Sharma etal., 1990). When hepatocytes are isolated from rats, which have been pretreated with a-tocopherol, there is a significant reduction in iron-induced lipid peroxidation and improvement in cell viability in vitro (Poli et al., 1985). Similar effects were seen when hepatocytes were incubated with iron chelators (Bacon and Britton, 1990). Treatment of moderately, but not heavily, iron-loaded rats with desferrioxamine in vivo inhibits the pro-oxidant activity of hepatic ultrafiltrates (Britton et al., 1990b). 

There have been more than 20 studies relating to the prevention of atherosclerosis by antioxidants. In vitro, several studies have shown that antioxidant treatment (e.g. vitamin E) inhibits both oxidation and the formation of cytotoxic LDL (Steinbrecher etal., 1984 Par-thasarathy etal., 1986 Esterbauer etal., 1987). In vivo, vitamin E supplementation prevents LDL oxidation in... 

---